Has Rod Oskouian, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,411,793 in general payments to Rod Oskouian, MD across 833 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rod Oskouian, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rod Oskouian, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rod Oskouian, MD

Neurological Surgery · Seattle, WANPI 1972710044

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $1,618,248 of the $2,411,793 with a category attached, or 67.1%. Stryker accounts for 71.3% of it on its own, with 25 other manufacturers making up the rest. Among neurological surgery clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,411,793in general payments, 2019–2025

Across 833 payments — averaging $2895.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$1.7M
Medtronic$403K
Globus Medical$97K
Orthofix Medical, Inc.$69K
Spineart USA Inc$47K
Seaspine Orthopedics Corporation$26K
plus $52K from 20 others

$82,206in research payments, 2019–2025

Across 10 payments — averaging $8220.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Spineart SA$82K

What the payments were for

Royalty or licence$1,618,24867%
Consulting fees$662,74127%
Speaking & faculty fees$24,6751%
Travel & lodging$83,8133%
Food & beverage$22,3151%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	106	$1,718,432
Medtronic(2 entities)	215	$402,613
Globus Medical(2 entities)	130	$96,931
Orthofix Medical, Inc.	118	$68,856
Spineart USA Inc	27	$46,787
Seaspine Orthopedics Corporation	51	$26,146
Alphatec Spine, Inc	25	$23,693
VB Spine LLC	8	$19,546
Johnson & Johnson(2 entities)	101	$4,340
Medical Device Business Services, Inc.	3	$1,373
Depuy Synthes Products, Inc.	20	$1,091
Surgalign Spine Technologies, Inc.	6	$581
Synthes GmbH	1	$250
Integra Lifesciences Corporation	2	$206
Bioventus LLC	2	$172
Centinel Spine, LLC	2	$160
Si-bone, Inc.	3	$156
Icotec Medical Inc.	1	$84
Kuros Biosciences USA, Inc	3	$79
Spineart SA	1	$68
Carbofix Spine Inc	1	$58
Providence Medical Technology, Inc.	1	$56
Xtant Medical Inc	2	$37
Cerapedics Inc.	1	$32
CTL Medical Corporation	2	$25
Zimmer Biomet	1	$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SERRATO$1,631,485
EVEREST SPINAL SYSTEM$41,880
Intradiscal Osteotomy$34,250
CD HORIZON SPINAL SYSTEM$28,983
MISCELLANEOUS$21,254
XIA 3$19,500
OASYS$19,500
MONTEREY AL$19,500
YUKON OCT SPINAL SYSTEM$18,811
CANYON RETRACTOR SYSTEMS$18,000
Romeo 2$17,749
Perla TL$16,462
Other - Miscellaneous$15,866
T2 STRATOSPHERE EXPANDABLE CORPECTOMY SYSTEM$14,758
Pelvic Screws$13,375
UNID_PASS$12,759
CREO$10,238
TLIF$7,500
LIF$7,386
RISE-L . RISE-L A/L$4,009

How this compares

$2,411,793 in reported general payments places this provider in the 95th percentile of 175 neurological surgery providers in Washington.

See all neurological surgery providers in Washington →

Medicare billing

Part B allowed, 2024

$165,300

Medicare patients

232

Services billed

464

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gabapentin	33	$588
Methylprednisolone	17	$124
Mupirocin	15	$94

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Seattle

Christoph HofstetterSeattle$768K
Stephen MonteithSeattle$151K
Jean-Christophe LevequeSeattle$120K
Vijay YanamadalaSeattle$85K
Hoan Vu TranSeattle$78K
Martin RutkowskiSeattle$62K
Bailey ZampellaSeattle$38K
Melanie WalkerSeattle$38K
Elias EliasSeattle$35K
Ryder GwinnSeattle$35K

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →